Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 6:20 PM UTC
| NCT Number | NCT07543055 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE1 |
| Target Enrollment | 36 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | June 30, 2026 (3 weeks ago) |
As of July 21, 2026: Clinical trial NCT07543055 is currently recruiting participants. This phase1 study for prostate cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07543055 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07543055 was last updated 3 weeks ago (June 30, 2026). HelloStudys verifies this status automatically.